GV has supported the initial tranche of a $75m series A round for Forty Seven, an immuno-oncology spinout of Stanford University.

Existing backers including GlaxoSmithKline and Roche were joined by Pfizer and Woodford Patient Capital for the Cambridge spinout's series C round.

Johnson and Johnson reinvested in Inivata, which will use the series A funding to advance its cancer diagnostics platform through clinical studies.

Mark Sherman, managing director of Telstra Ventures, said: "We are looking forward to working with Instart Logic to apply their technology in our business."

A fund co-created by Shanghai Jiao Ton University's investment unit backs Jerry Education's $40m round to open more schools and develop an online platform.

C4 Therapeutics has been launched by the Dana-Farber Cancer Institute with series A funding from investors including Roche, Novartis and Kraft.

Open access education platform Coursera has reached the second close of its Times Internet-backed series C round after securing a commitment by EDBI.

Lundbeck, Baxter and La Caixa have contributed to a series C round that will support clinical trials for Sanifit's treatments for dialysis patients.

Wearable electronics spinout MC10 raises $40m according to SEC filing.